Se rendre au contenu
· Biorevitalisation
SKU 11211

Viscoderm 1.6

En stock
Volume
3 x 1,5 mL
Laboratoire
IBSA
Origine
Italie
Indication
Biorevitalisation, biostimulation, age-related skin change
Zones de traitement
Prix professionnel et historique réservés aux comptes vérifiés
allpara approvisionne les praticiens agréés. Connectez-vous ou ouvrez un compte B2B pour voir les prix en temps réel, les paliers de volume et l'historique des prix.
Étiquettes

Viscoderm 1.6 is a sterile, single-use injectable hyaluronic acid medical device manufactured by IBSA Farmaceutici Italia S.r.l. It contains 24 mg of highly purified sodium hyaluronate in a 1.5 ml pre-filled syringe, equivalent to 16 mg/ml. The hyaluronic acid is obtained by fermentation, is not chemically modified, and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. It is intended for intradermal administration by qualified personnel and is indicated to counteract moderate xerodermia associated with dermatitis and/or psoriasis.

Principaux avantages de Viscoderm 1.6

  • Highly purified hyaluronic acid obtained by fermentation
  • Not chemically modified
  • Molecular weight of approximately 1 million Dalton
  • Supports restoration of physiological hyaluronic acid levels in treated tissue
  • Supports tissue rehydration
  • Helps create favourable conditions for tissue remodelling
  • Indicated for moderate xerodermia associated with dermatitis and/or psoriasis
  • High biocompatibility and excellent tolerability
  • Sterile, pyrogen-free and single-use
Informations clés
Marque Viscoderm
Fabricant IBSA
Pays d'origine Italy
Certification CE-marked medical device for intradermal use, CE 0477
Composition Per 1.5 ml syringe: sodium hyaluronate 24.000 mg; sodium chloride 12.750 mg; sodium phosphate 0.307 mg; water for injection q.s. 1.5 ml
Volume / Taille 1.5 ml per syringe, 4.5 ml per pack
Conditionnement 3 pre-filled syringes x 1.5 ml, with 6 needles 30G x 1/2 inch (0.3 x 12 mm)
Taille de l'aiguille 30G x 1/2 inch (0.3 x 12 mm), 6 needles supplied per pack
Type d'utilisation Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.
Profondeur d'injection Intradermal, at medium-deep level, using a linear or picotage technique
Protocole / Durée Initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Shelf life 36 months.

Indications et usage professionnel

Indications principales

  • Moderate xerodermia associated with dermatitis and/or psoriasis
  • Restoration of the normal physiological condition of the dermis
  • Rehydration of skin tissue where cell turnover of the stratum corneum is increased

Usage professionnel

Viscoderm 1.6 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Because the 1.5 ml pre-filled syringe allows a whole session to be completed with a single syringe, it is advisable to replace the needle halfway through the treatment, for example using two separate needles to treat the whole face. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.

Zones de traitement

  • Intradermal administration, at medium-deep level
  • The instructions for use do not restrict the device to named facial or body areas; the treating practitioner determines the area treated

Profil du patient

Viscoderm 1.6 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 1.6% concentration is indicated to counteract moderate xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.

Comment agit Viscoderm 1.6 ?

Viscoderm 1.6 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 1.6% concentration is the mid concentration of the three in the range and is the one indicated for moderate xerodermia.

Pourquoi commander chez Allpara

Allpara propose des produits VISCODERM authentiques et vérifiés, issus de fournisseurs contrôlés, avec une traçabilité complète des lots et un accompagnement expert. Nous servons les cliniques et les professionnels de l'esthétique avec des produits certifiés CE, une livraison rapide dans toute l'UE depuis notre entrepôt UE et des prix professionnels compétitifs. Notre priorité : la sécurité, la satisfaction et les résultats de vos patients, avec un service après-vente dédié pour votre tranquillité d'esprit.

Questions fréquentes

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml, equivalent to 16 mg/ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 1.6 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 1.6?

Viscoderm 1.6 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. The instructions for use also state that it should not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and that the injection site must be on healthy skin and free of inflammatory processes.

/ Spécifications

La fiche technique

Catégorie
Biorevitalisation
Marque
VISCODERM
Laboratoire
IBSA
SKU
11211
Format
3 x 1,5 mL
Origine
Italie
Indication
Biorevitalisation, biostimulation, age-related skin change
Utilisation
Injectable gel implant, professional use
Zones de traitement
/ Détails du produit

Le dossier complet

Viscoderm 1.6 is a sterile, single-use injectable hyaluronic acid medical device manufactured by IBSA Farmaceutici Italia S.r.l. It contains 24 mg of highly purified sodium hyaluronate in a 1.5 ml pre-filled syringe, equivalent to 16 mg/ml. The hyaluronic acid is obtained by fermentation, is not chemically modified, and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. It is intended for intradermal administration by qualified personnel and is indicated to counteract moderate xerodermia associated with dermatitis and/or psoriasis.

IBSA, pays d'origine Italie.

Expédié dans toute l'UE depuis notre entrepôt UE, avec suivi et assurance, sous 24-72 h. Chaque unité est livrée avec son numéro de lot et sa date de péremption, stockée sous douane dans l'UE et traçable par lot.

À conserver selon les spécifications du fabricant, à l'abri de la lumière directe. La chaîne du froid n'est utilisée que lorsque le produit l'exige.

Des conditions de paiement à 30 / 60 / 90 jours* sont proposées aux comptes vérifiés, sous réserve d'accord de crédit. Facturation possible en EUR, CHF et GBP.

Conditions indicatives, confirmées après examen du compte.

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml, equivalent to 16 mg/ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 1.6 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 1.6?

Viscoderm 1.6 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. The instructions for use also state that it should not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and that the injection site must be on healthy skin and free of inflammatory processes.

/ Réponses rapides

Les premières questions des acheteurs

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?
The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml, equivalent to 16 mg/ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.
Is the hyaluronic acid in Viscoderm 1.6 chemically modified?
No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.
Who should not be treated with Viscoderm 1.6?
Viscoderm 1.6 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. The instructions for use also state that it should not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and that the injection site must be on healthy skin and free of inflammatory processes.
/ FAQ

Questions fréquentes

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml, equivalent to 16 mg/ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.
No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.
Viscoderm 1.6 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. The instructions for use also state that it should not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and that the injection site must be on healthy skin and free of inflammatory processes.

Plus de produits IBSA

Voir le laboratoire

Alternatives pour la clinique

Tous les produits

Viscoderm 1.6

En stock
Marquage CE Marquage CE Viscoderm 1.6
Prix réservés aux comptes vérifiés
Connectez-vous ou ouvrez un compte B2B pour voir votre prix.
Ouvrir un compte B2B

Viscoderm 1.6 is a sterile, single-use injectable hyaluronic acid medical device manufactured by IBSA Farmaceutici Italia S.r.l. It contains 24 mg of highly purified sodium hyaluronate in a 1.5 ml pre-filled syringe, equivalent to 16 mg/ml. The hyaluronic acid is obtained by fermentation, is not chemically modified, and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. It is intended for intradermal administration by qualified personnel and is indicated to counteract moderate xerodermia associated with dermatitis and/or psoriasis.

Principaux avantages de Viscoderm 1.6

  • Highly purified hyaluronic acid obtained by fermentation
  • Not chemically modified
  • Molecular weight of approximately 1 million Dalton
  • Supports restoration of physiological hyaluronic acid levels in treated tissue
  • Supports tissue rehydration
  • Helps create favourable conditions for tissue remodelling
  • Indicated for moderate xerodermia associated with dermatitis and/or psoriasis
  • High biocompatibility and excellent tolerability
  • Sterile, pyrogen-free and single-use
Informations clés
Marque Viscoderm
Fabricant IBSA
Pays d'origine Italy
Certification CE-marked medical device for intradermal use, CE 0477
Composition Per 1.5 ml syringe: sodium hyaluronate 24.000 mg; sodium chloride 12.750 mg; sodium phosphate 0.307 mg; water for injection q.s. 1.5 ml
Volume / Taille 1.5 ml per syringe, 4.5 ml per pack
Conditionnement 3 pre-filled syringes x 1.5 ml, with 6 needles 30G x 1/2 inch (0.3 x 12 mm)
Taille de l'aiguille 30G x 1/2 inch (0.3 x 12 mm), 6 needles supplied per pack
Type d'utilisation Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.
Profondeur d'injection Intradermal, at medium-deep level, using a linear or picotage technique
Protocole / Durée Initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Shelf life 36 months.

Indications et usage professionnel

Indications principales

  • Moderate xerodermia associated with dermatitis and/or psoriasis
  • Restoration of the normal physiological condition of the dermis
  • Rehydration of skin tissue where cell turnover of the stratum corneum is increased

Usage professionnel

Viscoderm 1.6 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Because the 1.5 ml pre-filled syringe allows a whole session to be completed with a single syringe, it is advisable to replace the needle halfway through the treatment, for example using two separate needles to treat the whole face. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.

Zones de traitement

  • Intradermal administration, at medium-deep level
  • The instructions for use do not restrict the device to named facial or body areas; the treating practitioner determines the area treated

Profil du patient

Viscoderm 1.6 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 1.6% concentration is indicated to counteract moderate xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.

Comment agit Viscoderm 1.6 ?

Viscoderm 1.6 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 1.6% concentration is the mid concentration of the three in the range and is the one indicated for moderate xerodermia.

Pourquoi commander chez Allpara

Allpara propose des produits VISCODERM authentiques et vérifiés, avec une traçabilité complète des lots, un stock certifié CE, une livraison rapide dans toute l'UE et un service après-vente expert.

Questions fréquentes

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml, equivalent to 16 mg/ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 1.6 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 1.6?

Viscoderm 1.6 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. The instructions for use also state that it should not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and that the injection site must be on healthy skin and free of inflammatory processes.

Plus de produits IBSA

Voir le laboratoire →

Viscoderm 1.6 is a sterile, single-use injectable hyaluronic acid medical device manufactured by IBSA Farmaceutici Italia S.r.l. It contains 24 mg of highly purified sodium hyaluronate in a 1.5 ml pre-filled syringe, equivalent to 16 mg/ml. The hyaluronic acid is obtained by fermentation, is not chemically modified, and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. It is intended for intradermal administration by qualified personnel and is indicated to counteract moderate xerodermia associated with dermatitis and/or psoriasis.

IBSA, pays d'origine Italie.

Expédié dans toute l'UE depuis notre entrepôt UE, sous 24-72 h, avec suivi et assurance. Chaque unité est livrée avec son numéro de lot et sa date de péremption, stockée sous douane dans l'UE et traçable par lot. À conserver selon les spécifications du fabricant.

Paiement à 30 / 60 / 90 jours* pour les comptes vérifiés, sous réserve d'accord de crédit. Facturation en EUR, CHF et GBP.

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml, equivalent to 16 mg/ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 1.6 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 1.6?

Viscoderm 1.6 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. The instructions for use also state that it should not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and that the injection site must be on healthy skin and free of inflammatory processes.

* Produit à usage professionnel. L'emballage peut varier selon le lot ou le marché. Consultez la notice fournie pour le mode d'emploi complet et les contre-indications.